1,417 results on '"Guan, Xin-Yuan"'
Search Results
2. Fibroblasts in metastatic lymph nodes confer cisplatin resistance to ESCC tumor cells via PI16
3. Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression
4. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction
5. Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma
6. PPM1G promotes cell proliferation via modulating mutant GOF p53 protein expression in hepatocellular carcinoma
7. Exploring treatment options in cancer: Tumor treatment strategies
8. HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer
9. LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer
10. Identification and Characterization of Metastasis‐Initiating Cells in ESCC in a Multi‐Timepoint Pulmonary Metastasis Mouse Model
11. Optimal time for early therapeutic response prediction in nasopharyngeal carcinoma with functional magnetic resonance imaging
12. GLIPR1 promotes proliferation, metastasis and 5-fluorouracil resistance in hepatocellular carcinoma by activating the PI3K/PDK1/ROCK1 pathway
13. Roles of heat shock proteins in tumor immune microenvironment
14. Ferroptosis: Promising approach for cancer and cancer immunotherapy
15. The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer
16. A T cell resilience model associated with response to immunotherapy in multiple tumor types
17. Figure S3 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
18. Data from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
19. Supplementary Tables from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
20. FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
21. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer
22. PITX2C increases the stemness features of hepatocellular carcinoma cells by up-regulating key developmental factors in liver progenitor
23. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma
24. HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma
25. Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma
26. Potential synthetic lethality for breast cancer: A selective sirtuin 2 inhibitor combined with a multiple kinase inhibitor sorafenib
27. Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor
28. Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
29. The RARS–MAD1L1 Fusion Gene Induces Cancer Stem Cell–like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma
30. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets
31. PGC7 promotes tumor oncogenic dedifferentiation through remodeling DNA methylation pattern for key developmental transcription factors
32. DAPK3 inhibits gastric cancer progression via activation of ULK1-dependent autophagy
33. Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism
34. C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism
35. A neural‐related gene risk score for head and neck squamous cell carcinoma.
36. Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma
37. PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma
38. Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17
39. Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma
40. RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2
41. Genome-wide identification of key regulatory lncRNAs in esophageal cancer metastasis
42. Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits
43. Publisher Correction: A T cell resilience model associated with response to immunotherapy in multiple tumor types
44. Loss of ESRP2 Activates TAK1‐MAPK Signaling through the Fetal RNA‐Splicing Program to Promote Hepatocellular Carcinoma Progression
45. 964 Single-cell spatial characterization of microenvironmental impacts on immunotherapy discrepancies between adult and pediatric nasopharyngeal carcinoma patients
46. Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma
47. Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis
48. CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3
49. HOXC10 upregulation confers resistance to chemoradiotherapy in ESCC tumor cells and predicts poor prognosis
50. Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.